CUVITRU is indicated as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients ≥2 years. CUVITRU is for subcutaneous use only.
CUVITRU is indicated as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients ≥2 years. CUVITRU is for subcutaneous use only.
Whether your patients prefer infusions that take less than an hour or fewer needlesticks, CUVITRU [Immune Globulin Subcutaneous (Human)] 20% Solution is the SCIG of choice with administration that can be customized to meet their individual needs.1,2
The median duration of once-weekly infusions was <1 hour (0.95 hours; range: 0.2-6.4 hours) in the North American clinical study.
84.9% of infusions (N=4314) were administered using only 1 or 2 infusion sites (18.5%=1 site; 66.4%=2 sites) in the North American clinical study.
Patients who had received IVIG previously reported that CUVITRU fit better into their schedules and was more convenient than IVIG infusion.†
*If a patient is 75 kg (165 lbs) and was prescribed 36 g of IVIG per month, you could switch your patient to 12 g of CUVITRU weekly. After the first 2 infusions, subsequent infusions of CUVITRU could be completed in 15 mins at a rate of 60 mL/h/site using 4 sites simultaneously.
†CUVITRU was shown to significantly improve patient quality of life in terms of Convenience (TSQM-9 difference 11.11; P<0.001) and Treatment Interference (LQI difference 1.50; P=0.008) when compared to IVIG treatment.
See how CUVITRU is administered.
Watch the video to learn more about CUVITRU administration.
There are known risk factors to consider with Cuvitru. Review the full safety information, including contraindications and specific warnings and precautions to take when monitoring patients with Cuvitru.
See Safety InformationView examples of 3 patients’ infusion sites from pre-infusion to 48 hours after.
Volume infused per physician guidance based on patient’s specific clinical condition. It may be different for other patients.
Patient No. 1
Male, age 59
Patient No. 2
Male, age 16
Explore administration parameter combinations based on needlesticks and infusion frequency, plus learn about the proper ancillary supplies.
Infusion Calculator & Ancillary Supplies